| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
CC chemokine receptor 5 (CCR5) functions physiologically as a
receptor for the leukocyte chemoattractants macrophage inflammatory
protein-1
, macrophage inflammatory protein-1ß, and RANTES, and
functions pathologically as a key cell entry coreceptor for HIV-1. The
factors that regulate CCR5 expression may be useful therapeutic targets
for HIV-1 infection. To identify nuclear regulatory factors, we have
located and functionally characterized the CCR5 gene promoter. The gene
consists of two exons separated by a 1.9-kb intron. Exon 1 contains 43
bp of the 5'-untranslated region; exon 2 contains 11 bp of the
5'-untranslated region and the complete open reading frame. Primer
extension analysis identified two adjacent transcriptional start points
(tsp) that map to the first 2 bp found in the longest known CCR5 cDNA
sequence. A TATA box is present 31 bp upstream from the first tsp. CCR5
mRNA was detected constitutively in both primary human myeloid and
lymphoid cells by Northern blot hybridization. Consistent with this,
transcription of a chloramphenicol acetyltransferase reporter gene was
constitutively activated in both transiently transfected myeloid and
lymphoid cell lines by the 80-bp gene fragment located immediately
upstream of the tsp. Deletion analysis located a strong silencer
element between nucleotides -244 and -80, and a strong enhancer
element between -486 and -244. These results suggest that the gene
region between -486 and -1 may regulate the expression of CCR5 in
monocyte/macrophages and T lymphocytes.
This article has been cited by other articles:
|
|
 |
|
  Q. Jin, L. Agrawal, L. Meyer, R. Tubiana, I. Theodorou, and G. Alkhatib CCR5{Delta}32 59537-G/A Promoter Polymorphism Is Associated with Low Translational Efficiency and the Loss of CCR5{Delta}32 Protective Effects J. Virol., March 1, 2008; 82(5): 2418 - 2426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Weinberg, S. Barichievy, L. Schaffer, J. Han, and K. V. Morris An RNA targeted to the HIV-1 LTR promoter modulates indiscriminate off-target gene activation Nucleic Acids Res., December 18, 2007; 35(21): 7303 - 7312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mummidi, L. M. Adams, S. E. VanCompernolle, M. Kalkonde, J. F. Camargo, H. Kulkarni, A. S. Bellinger, G. Bonello, H. Tagoh, S. S. Ahuja, et al. Production of Specific mRNA Transcripts, Usage of an Alternate Promoter, and Octamer-Binding Transcription Factors Influence the Surface Expression Levels of the HIV Coreceptor CCR5 on Primary T Cells J. Immunol., May 1, 2007; 178(9): 5668 - 5681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Phillips, V. E. L. Stubbs, M. R. Henson, T. J. Williams, J. E. Pease, and I. Sabroe Variations in Eosinophil Chemokine Responses: An Investigation of CCR1 and CCR3 Function, Expression in Atopy, and Identification of a Functional CCR1 Promoter J. Immunol., June 15, 2003; 170(12): 6190 - 6201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rosati, A. Valentin, D. J. Patenaude, and G. N. Pavlakis CCAAT-Enhancer-Binding Protein {beta} (C/EBP{beta}) Activates CCR5 Promoter: Increased C/EBP{beta} and CCR5 in T Lymphocytes from HIV-1-Infected Individuals J. Immunol., August 1, 2001; 167(3): 1654 - 1662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Zimmermann, B. L. Daugherty, J. L. Kavanaugh, F. Y. El-Awar, E. A. Moulton, and M. E. Rothenberg Analysis of the CC chemokine receptor 3 gene reveals a complex 5' exon organization, a functional role for untranslated exon 1, and a broadly active promoter with eosinophil-selective elements Blood, October 1, 2000; 96(7): 2346 - 2354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Wahl, T. Greenwell-Wild, H. Hale-Donze, N. Moutsopoulos, and J. M. Orenstein Permissive factors for HIV-1 infection of macrophages J. Leukoc. Biol., September 1, 2000; 68(3): 303 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Pierson, T. L. Hoffman, J. Blankson, D. Finzi, K. Chadwick, J. B. Margolick, C. Buck, J. D. Siliciano, R. W. Doms, and R. F. Siliciano Characterization of Chemokine Receptor Utilization of Viruses in the Latent Reservoir for Human Immunodeficiency Virus Type 1 J. Virol., September 1, 2000; 74(17): 7824 - 7833. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Carrington, M. Dean, M. P. Martin, and StephenJ. O'Brien Genetics of HIV-1infection: chemokine receptor CCR5 polymorphism and its consequences Hum. Mol. Genet., September 1, 1999; 8(10): 1939 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mariani, S. Wong, L. C. F. Mulder, D. A. Wilkinson, A. L. Reinhart, G. LaRosa, R. Nibbs, T. R. O'Brien, N. L. Michael, R. I. Connor, et al. CCR2-64I Polymorphism Is Not Associated with Altered CCR5 Expression or Coreceptor Function J. Virol., March 1, 1999; 73(3): 2450 - 2459. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. M. Wahl, T. Greenwell-Wild, G. Peng, H. Hale-Donze, T. M. Doherty, D. Mizel, and J. M. Orenstein Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression PNAS, October 13, 1998; 95(21): 12574 - 12579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mummidi, M. Bamshad, S. S. Ahuja, E. Gonzalez, P. M. Feuillet, K. Begum, M. C. Galvis, V. Kostecki, A. J. Valente, K. K. Murthy, et al. Evolution of Human and Non-human Primate CC Chemokine Receptor 5 Gene and mRNA. POTENTIAL ROLES FOR HAPLOTYPE AND mRNA DIVERSITY, DIFFERENTIAL HAPLOTYPE-SPECIFIC TRANSCRIPTIONAL ACTIVITY, AND ALTERED TRANSCRIPTION FACTOR BINDING TO POLYMORPHIC NUCLEOTIDES IN THE PATHOGENESIS OF HIV-1 AND SIMIAN IMMUNODEFICIENCY VIRUS J. Biol. Chem., June 16, 2000; 275(25): 18946 - 18961. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
